The protective effects of saxagliptin against lipopolysaccharide (LPS)-induced inflammation and damage in human dental pulp cells

References

• Rechenberg DK, Galicia JC, Peters OA. Biological markers for pulpal inflammation: a systematic review. PLoS One. 2016;11:e0167289.
   PubMed Web of Science ®Google Scholar
• Hahn CL, Liewehr FR. Relationships between caries bacteria, host responses, and clinical signs and symptoms of pulpitis. J Endod. 2007;33:213–219.
   PubMed Web of Science ®Google Scholar
• Hicks G, Jia Z. Structural basis for the lipopolysaccharide export activity of the bacterial lipopolysaccharide transport system. Int J Mol Sci. 2018;19:2680.
   PubMed Web of Science ®Google Scholar
• Chung MK, Lee J, Duraes G, et al. Lipopolysaccharide-induced pulpitis up-regulates TRPV1 in trigeminal ganglia. J Dent Res. 2011;90:1103–1107.
   PubMed Web of Science ®Google Scholar
• Jung JY, Woo SM, Kim WJ, et al. Simvastatin inhibits the expression of inflammatory cytokines and cell adhesion molecules induced by LPS in human dental pulp cells. Int Endod J. 2017;50:377–386.
   PubMed Web of Science ®Google Scholar
• Borio A, Holgado A, Garate JA, et al. Disaccharide-based anionic amphiphiles as potent inhibitors of lipopolysaccharide-induced inflammation. Chem Med Chem. 2018;13:2317–2331.
   Web of Science ®Google Scholar
• Hirsch V, Wolgin M, Mitronin AV, et al. Inflammatory cytokines in normal and irreversibly inflamed pulps: a systematic review. Arch Oral Biol. 2017;82:38–46.
   PubMed Web of Science ®Google Scholar
• Liu L, Huang R, Yang R, et al. OCT4B1 regulates the cellular stress response of human dental pulp cells with inflammation. Biomed Res Int. 2017;2017:2756891.
   PubMed Web of Science ®Google Scholar
• He W, Qu T, Yu Q, et al. LPS induces IL-8 expression through TLR4, MyD88, NF-kappaB and MAPK pathways in human dental pulp stem cells. Int Endod J. 2013;46:128–136.
   PubMed Web of Science ®Google Scholar
• He W, Wang Z, Zhou Z, et al. Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells. J Endod. 2014;40:69–75.
   PubMed Web of Science ®Google Scholar
• Men P, Li XT, Tang HL, et al. Efficacy and safety of saxagliptin in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2018;13:e0197321.
   PubMed Web of Science ®Google Scholar
• Billiones R. Saxagliptin in type 2 diabetes. Drugs Today. 2010;46:101–108.
   PubMed Web of Science ®Google Scholar
• Dore FJ, Domingues CC, Ahmadi N, et al. The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial. Cardiovasc Diabetol. 2018;17:65.
   PubMed Web of Science ®Google Scholar
• Brown SM, Smith CE, Meuth AI, et al. Dipeptidyl peptidase-4 inhibition with saxagliptin ameliorates angiotensin ii-induced cardiac diastolic dysfunction in male mice. Endocrinology. 2017;158:3592–3604.
   PubMed Web of Science ®Google Scholar
• Birnbaum Y, Bajaj M, Qian J, et al. Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome. BMJ Open Diab Res Care. 2016;4:e000227.
   PubMed Web of Science ®Google Scholar
• Catanzaro O, Dziubecki D, Lauria LC, et al. Diabetes and its effects on dental pulp. J Oral Sci. 2006;48:195–199.
   PubMedGoogle Scholar
• Jafarlou M, Shanehbandi D, Dehghan P, et al. Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia. Artif Cells Nanomed Biotechnol. 2018;46:1792–1798.
   PubMed Web of Science ®Google Scholar
• Fatima F, Pathak N, Verma SR, et al. Toxicity and immunomodulatory efficacy of biosynthesized silver myconanosomes on pathogenic microbes and macrophage cells. Artif Cells Nanomed Biotechnol. 2018;46:1637–1645.
   PubMed Web of Science ®Google Scholar
• Sheng B, Gong K, Niu Y, et al. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: implications for the treatment of Alzheimer’s disease. Free Radic Biol Med. 2009;46:1362–1375.
   PubMed Web of Science ®Google Scholar
• De Nigris V, Prattichizzo F, Mancuso E, et al. Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions. Oncotarget. 2017;9:8898–8910.
   PubMedGoogle Scholar
• Hernández Vigueras S, Donoso Zúñiga M, Jané-Salas E, et al. Viruses in pulp and periapical inflammation: a review. Odontology. 2016;104:184–191.
   PubMed Web of Science ®Google Scholar
• Zhang L, Bai L, Ren Q, et al. Protective effects of SIRT6 against lipopolysaccharide (LPS) are mediated by deacetylation of Ku70. Mol Immunol. 2018;101:312–318.
   PubMed Web of Science ®Google Scholar
• Nephan G, Coskun ZM, Bolkent S. Dipeptidyl peptidase-4 inhibition prevents cell death via extrinsic and intrinsic apoptotic pathways in rat pancreas with insulin resistance. Cell Biochem Funct. 2018;36:212–220.
   PubMed Web of Science ®Google Scholar
• Singh TP, Vangaveti VN, Malabu UH. Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis–A review. Diabetes Metab Syndr. 2015;9:223–229.
   PubMed Web of Science ®Google Scholar
• Mason RP, Jacob RF, Kubant R, et al. Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats. J Atheroscler Thromb. 2011;18:774–783.
   PubMed Web of Science ®Google Scholar
• Mason RP, Jacob RF, Kubant R, et al. Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats. J Cardiovasc Pharmacol. 2012;60:467–473.
   PubMed Web of Science ®Google Scholar
• Tang J, Luo K, Li Y, et al. Capsaicin attenuates LPS-induced inflammatory cytokine production by upregulation of LXRa. Int Immunopharmacol. 2015;28:264–269.
   PubMed Web of Science ®Google Scholar
• Kim DS, Shin MR, Kim YS, et al. Anti-inflammatory effects of glutamine on LPS-stimulated human dental pulp cells correlate with activation of MKP-1 and attenuation of the MAPK and NF-κB pathways. Int Endod J. 2015;48:220–228.
   PubMed Web of Science ®Google Scholar
• Lee SI, Min KS, Bae WJ, et al. Role of SIRT1 in heat stress – and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cells. J Endod. 2011;37:1525–1530.
   PubMed Web of Science ®Google Scholar
• Chen J, Stark LA. Crosstalk between NF-κB and nucleoli in the regulation of cellular homeostasis. Cells. 2018;7:157.
   PubMed Web of Science ®Google Scholar
• Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang CL, Li RM, et al. Wnt5a promotes inflammatory responses via nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells. J Biol Chem. 2014;289:21028–21039.
   PubMed Web of Science ®Google Scholar
• Gangadharan Komala M, Gross S, Zaky A, et al. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes. Nephrology (Carlton). 2016;21:423–431.
   PubMed Web of Science ®Google Scholar
• Giridharan S, Srinivasan M. Mechanisms of NF-κB p65 and strategies for therapeutic manipulation. J Inflamm Res. 2018;11:407–419.
   PubMed Web of Science ®Google Scholar